Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Public ClinicalTrials.gov record NCT00157105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures
Study identification
- NCT ID
- NCT00157105
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Baxalta now part of Shire
- Industry
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Interventions
- Antihemophilic factor, recombinant, manufactured protein-free Drug
Drug
Eligibility (public fields only)
- Age range
- 5 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 11, 2001
- Primary completion
- Aug 2, 2004
- Completion
- Aug 2, 2004
- Last update posted
- Aug 23, 2021
2001 – 2004
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children´s Hospital Los Angeles, Hemophilia Comprehensive Care Center, Division of Pediatric Hematology/Oncology | Los Angeles | California | 90027 | — |
| Children´s Healthcare of Atlanta Blood Bank | Atlanta | Georgia | 30322 | — |
| Indiana Hemophilia & Thrombosis Center | Indianapolis | Indiana | 46260 | — |
| University of Iowa Hospitals and Clinics, Iowa Regional Hemophilia Center, Department of Pediatrics | Iowa City | Iowa | 52242 | — |
| Brigham and Women´s Hospital, Hematology Division | Boston | Massachusetts | 02115 | — |
| Michigan State University | East Lansing | Michigan | 48824 | — |
| Mt. Sinai Medical School, Hemophilia Comprehensive Care Center | New York | New York | 10029 | — |
| Children´s Hospital Medical Center Pharmacy, Hemophilia Treatment Center | Cincinnati | Ohio | 45229 | — |
| Hemophilia Center of Western Pennsylvania | Pittsburgh | Pennsylvania | 15213-4306 | — |
| Puget Sound Blood Center | Seattle | Washington | 98104-1256 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00157105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2021 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00157105 live on ClinicalTrials.gov.